WHO Global Situational Alert System : a mixed methods multistage approach to identify country-level COVID-19 alerts
© World Health Organization 2023. Licensee BMJ..
BACKGROUND: Globally, since 1 January 2020 and as of 24 January 2023, there have been over 664 million cases of COVID-19 and over 6.7 million deaths reported to WHO. WHO developed an evidence-based alert system, assessing public health risk on a weekly basis in 237 countries, territories and areas from May 2021 to June 2022. This aimed to facilitate the early identification of situations where healthcare capacity may become overstretched.
METHODS: The process involved a three-stage mixed methods approach. In the first stage, future deaths were predicted from the time series of reported cases and deaths to produce an initial alert level. In the second stage, this alert level was adjusted by incorporating a range of contextual indicators and accounting for the quality of information available using a Bayes classifier. In the third stage, countries with an alert level of 'High' or above were added to an operational watchlist and assistance was deployed as needed.
RESULTS: Since June 2021, the system has supported the release of more than US$27 million from WHO emergency funding, over 450 000 rapid antigen diagnostic testing kits and over 6000 oxygen concentrators. Retrospective evaluation indicated that the first two stages were needed to maximise sensitivity, where 44% (IQR 29%-67%) of weekly watchlist alerts would not have been identified using only reported cases and deaths. The alerts were timely and valid in most cases; however, this could only be assessed on a non-representative sample of countries with hospitalisation data available.
CONCLUSIONS: The system provided a standardised approach to monitor the pandemic at the country level by incorporating all available data on epidemiological analytics and contextual assessments. While this system was developed for COVID-19, a similar system could be used for future outbreaks and emergencies, with necessary adjustments to parameters and indicators.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
BMJ global health - 8(2023), 7 vom: 26. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
McMenamin, Martina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 03.08.2023 Date Revised 03.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjgh-2023-012241 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359953832 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359953832 | ||
| 003 | DE-627 | ||
| 005 | 20231226081956.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjgh-2023-012241 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1199.xml |
| 035 | |a (DE-627)NLM359953832 | ||
| 035 | |a (NLM)37495371 | ||
| 035 | |a (PII)e012241 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a McMenamin, Martina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a WHO Global Situational Alert System |b a mixed methods multistage approach to identify country-level COVID-19 alerts |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.08.2023 | ||
| 500 | |a Date Revised 03.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © World Health Organization 2023. Licensee BMJ. | ||
| 520 | |a BACKGROUND: Globally, since 1 January 2020 and as of 24 January 2023, there have been over 664 million cases of COVID-19 and over 6.7 million deaths reported to WHO. WHO developed an evidence-based alert system, assessing public health risk on a weekly basis in 237 countries, territories and areas from May 2021 to June 2022. This aimed to facilitate the early identification of situations where healthcare capacity may become overstretched | ||
| 520 | |a METHODS: The process involved a three-stage mixed methods approach. In the first stage, future deaths were predicted from the time series of reported cases and deaths to produce an initial alert level. In the second stage, this alert level was adjusted by incorporating a range of contextual indicators and accounting for the quality of information available using a Bayes classifier. In the third stage, countries with an alert level of 'High' or above were added to an operational watchlist and assistance was deployed as needed | ||
| 520 | |a RESULTS: Since June 2021, the system has supported the release of more than US$27 million from WHO emergency funding, over 450 000 rapid antigen diagnostic testing kits and over 6000 oxygen concentrators. Retrospective evaluation indicated that the first two stages were needed to maximise sensitivity, where 44% (IQR 29%-67%) of weekly watchlist alerts would not have been identified using only reported cases and deaths. The alerts were timely and valid in most cases; however, this could only be assessed on a non-representative sample of countries with hospitalisation data available | ||
| 520 | |a CONCLUSIONS: The system provided a standardised approach to monitor the pandemic at the country level by incorporating all available data on epidemiological analytics and contextual assessments. While this system was developed for COVID-19, a similar system could be used for future outbreaks and emergencies, with necessary adjustments to parameters and indicators | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Public Health | |
| 700 | 1 | |a Kolmer, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Djordjevic, Irena |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Finlay |e verfasserin |4 aut | |
| 700 | 1 | |a Laurenson-Schafer, Henry |e verfasserin |4 aut | |
| 700 | 1 | |a Abbate, Jessica Lee |e verfasserin |4 aut | |
| 700 | 1 | |a Abdelgawad, Basma Mostafa |e verfasserin |4 aut | |
| 700 | 1 | |a Babu, Amarnath |e verfasserin |4 aut | |
| 700 | 1 | |a Balde, Thierno |e verfasserin |4 aut | |
| 700 | 1 | |a Batra, Neale |e verfasserin |4 aut | |
| 700 | 1 | |a Bélorgeot, Victoria D |e verfasserin |4 aut | |
| 700 | 1 | |a Brindle, Hannah |e verfasserin |4 aut | |
| 700 | 1 | |a Dorji, Tshewang |e verfasserin |4 aut | |
| 700 | 1 | |a Esmail, Marjam |e verfasserin |4 aut | |
| 700 | 1 | |a Hammermeister Nezu, Ingrid |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández-García, Lucía |e verfasserin |4 aut | |
| 700 | 1 | |a Hassan, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Idoko, Friday |e verfasserin |4 aut | |
| 700 | 1 | |a Karmin, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Kassamali, Zyleen A |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Masaya |e verfasserin |4 aut | |
| 700 | 1 | |a Matsui, Tamano |e verfasserin |4 aut | |
| 700 | 1 | |a Duan, Mengjuan |e verfasserin |4 aut | |
| 700 | 1 | |a Motaze, Villyen |e verfasserin |4 aut | |
| 700 | 1 | |a Ogundiran, Opeayo |e verfasserin |4 aut | |
| 700 | 1 | |a Pavlin, Boris I |e verfasserin |4 aut | |
| 700 | 1 | |a Riviere-Cinnamond, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Ryan, Kathleen |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidt, Tanja |e verfasserin |4 aut | |
| 700 | 1 | |a Sedai, Tika |e verfasserin |4 aut | |
| 700 | 1 | |a Van Kerkhove, Maria D |e verfasserin |4 aut | |
| 700 | 1 | |a Zakaria, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Höhle, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Mahamud, Abdi R |e verfasserin |4 aut | |
| 700 | 1 | |a le Polain de Waroux, Olivier |e verfasserin |4 aut | |
| 700 | 0 | |a WHO Global Situational Alert System Group |e verfasserin |4 aut | |
| 700 | 1 | |a Cocciolone, Dominic |e investigator |4 oth | |
| 700 | 1 | |a Gapp, Christian |e investigator |4 oth | |
| 700 | 1 | |a King, Kayla |e investigator |4 oth | |
| 700 | 1 | |a Latta, Aimee |e investigator |4 oth | |
| 700 | 1 | |a Lindmark, Sandra |e investigator |4 oth | |
| 700 | 1 | |a Owen, Lisa |e investigator |4 oth | |
| 700 | 1 | |a Perehinets, Ihor |e investigator |4 oth | |
| 700 | 1 | |a Gimma, Amy |e investigator |4 oth | |
| 700 | 1 | |a McKnight, Jason |e investigator |4 oth | |
| 700 | 1 | |a Mesle, Margaux |e investigator |4 oth | |
| 700 | 1 | |a Pebody, Richard |e investigator |4 oth | |
| 700 | 1 | |a Mook, Piers |e investigator |4 oth | |
| 700 | 1 | |a Van Haverbeke, Maarten |e investigator |4 oth | |
| 700 | 1 | |a Amar, Tamar |e investigator |4 oth | |
| 700 | 1 | |a Cheng, Ka Yeung |e investigator |4 oth | |
| 700 | 1 | |a Ciobanu, Silviu |e investigator |4 oth | |
| 700 | 1 | |a MacDonald, Lauren E |e investigator |4 oth | |
| 700 | 1 | |a Pires, Jeff |e investigator |4 oth | |
| 700 | 1 | |a Pukkila, Jukka |e investigator |4 oth | |
| 700 | 1 | |a Roman, Celine |e investigator |4 oth | |
| 700 | 1 | |a Skrowny, Laila |e investigator |4 oth | |
| 700 | 1 | |a Tadevosyan, Ara |e investigator |4 oth | |
| 700 | 1 | |a Smallwood, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Ikejezie, Juniorcaius |e investigator |4 oth | |
| 700 | 1 | |a Greene-Cramer, Blanche Johanna |e investigator |4 oth | |
| 700 | 1 | |a Awofisayo-Okuyelu, Adedoyin Abiola |e investigator |4 oth | |
| 700 | 1 | |a Mirembe, Bernadette |e investigator |4 oth | |
| 700 | 1 | |a Guinko, Tondri Noe |e investigator |4 oth | |
| 700 | 1 | |a Attar-Cohen, Homa |e investigator |4 oth | |
| 700 | 1 | |a Shimizu, Kazuki |e investigator |4 oth | |
| 700 | 1 | |a Adele, Sandra |e investigator |4 oth | |
| 700 | 1 | |a Koyie, Stephen Leshan |e investigator |4 oth | |
| 700 | 1 | |a Mesfin, Samuel |e investigator |4 oth | |
| 700 | 1 | |a Cristea, Veronica |e investigator |4 oth | |
| 700 | 1 | |a Sklenovska, Nikola |e investigator |4 oth | |
| 700 | 1 | |a Mahran, Mostafa |e investigator |4 oth | |
| 700 | 1 | |a Hammer, Charlotte Christiane |e investigator |4 oth | |
| 700 | 1 | |a Meyer, Emily |e investigator |4 oth | |
| 700 | 1 | |a Brough, Grace |e investigator |4 oth | |
| 700 | 1 | |a Lata, Harsh |e investigator |4 oth | |
| 700 | 1 | |a Miglietta, Alessandro |e investigator |4 oth | |
| 700 | 1 | |a Parikh, Sydel |e investigator |4 oth | |
| 700 | 1 | |a Togami, Eri |e investigator |4 oth | |
| 700 | 1 | |a Izawa, Yurie |e investigator |4 oth | |
| 700 | 1 | |a Escobar Corado Waeber, Aura Rocio |e investigator |4 oth | |
| 700 | 1 | |a Rico Chinchilla, Anahi |e investigator |4 oth | |
| 700 | 1 | |a Jin, Yeo Won |e investigator |4 oth | |
| 700 | 1 | |a Medialdea Carrera, Raquel |e investigator |4 oth | |
| 700 | 1 | |a Artazcoz Glaria, Amaia |e investigator |4 oth | |
| 700 | 1 | |a Maes, Sophie |e investigator |4 oth | |
| 700 | 1 | |a Kim, Hyo Jeong |e investigator |4 oth | |
| 700 | 1 | |a Tayyab, Muhammed |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ global health |d 2016 |g 8(2023), 7 vom: 26. Juli |w (DE-627)NLM262254549 |x 2059-7908 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2023 |g number:7 |g day:26 |g month:07 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjgh-2023-012241 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2023 |e 7 |b 26 |c 07 | ||